Net Income (Loss) Attributable to Parent of Medicus Pharma Ltd. from 31 Dec 2023 to 30 Sep 2025

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Medicus Pharma Ltd. quarterly and annual Net Income (Loss) Attributable to Parent in USD history and change rate from 31 Dec 2023 to 30 Sep 2025.
  • Medicus Pharma Ltd. Net Income (Loss) Attributable to Parent for the quarter ending 30 Sep 2025 was $20,935,753, a 819% decline year-over-year.
  • Medicus Pharma Ltd. annual Net Income (Loss) Attributable to Parent for 2024 was $11,155,516, a 110% decline from 2023.
Source SEC data
View on sec.gov
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Change (%)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Change (%)

Medicus Pharma Ltd. Quarterly Net Income (Loss) Attributable to Parent (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
Q3 2025 $20,935,753 -$18,657,006 -819% 01 Jul 2025 30 Sep 2025 10-Q 14 Nov 2025 2025 Q3
Q1 2025 $5,102,408 -$3,395,050 -199% 01 Jan 2025 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q3 2024 $2,278,747 01 Jul 2024 30 Sep 2024 10-Q 14 Nov 2025 2025 Q3
Q1 2024 $1,707,358 01 Jan 2024 31 Mar 2024 10-Q 12 May 2025 2025 Q1

Medicus Pharma Ltd. Annual Net Income (Loss) Attributable to Parent (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed Fiscal Year Fiscal Period
2024 $11,155,516 -$5,840,751 -110% 01 Jan 2024 31 Dec 2024 10-K 28 Mar 2025 2024 FY
2023 $5,314,765 01 Jan 2023 31 Dec 2023 10-K 28 Mar 2025 2024 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.